(Apex) CGT9486 in Patients With Advanced Systemic Mastocytosis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Cogent Biosciences, Inc.
- ID
- NCT04996875
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 140 study participants
- Last Updated